SynthesisDrug safety2020
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
Miranda Davies et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled itcites it
SynthesisDrug safety2020
Miranda Davies et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.